Diagnostics company founded in 2012 in Redwood City, California. Guardant develops liquid biopsy tests for cancer detection and monitoring, analyzing circulating tumor DNA (ctDNA). Its flagship products include Guardant360® for advanced cancer profiling and Shield™ for early detection. Guardant partners with pharma for trial support and with healthcare systems for clinical adoption. (guardanthealt...